Treatment of a patient with conjunctival melanoma and V600E-positive BRAF mutation status with Vemurafenib

被引：0
|
作者：
Kiecker, Felix
Ewald, Kerstin
Bertelmann, Eckart
Trefzer, Uwe
机构：
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2012年 / 10卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：690 / 690
页数：1
相关论文
共 50 条
  • [1] Vemurafenib in Melanoma with BRAF V600E Mutation
    Morita, Hiroyuki
    Nagai, Ryozo
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (15): : 1448 - 1448
  • [2] Vemurafenib in Melanoma with BRAF V600E Mutation REPLY
    Chapman, Paul B.
    Hauschild, Axel
    McArthur, Grant A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (15): : 1450 - 1450
  • [3] Vemurafenib in Patients With BRAF V600E Mutation-Positive Advanced Melanoma
    Ravnan, Marcus C.
    Matalka, Mazen S.
    CLINICAL THERAPEUTICS, 2012, 34 (07) : 1474 - 1486
  • [4] Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
    Chapman, Paul B.
    Hauschild, Axel
    Robert, Caroline
    Haanen, John B.
    Ascierto, Paolo
    Larkin, James
    Dummer, Reinhard
    Garbe, Claus
    Testori, Alessandro
    Maio, Michele
    Hogg, David
    Lorigan, Paul
    Lebbe, Celeste
    Jouary, Thomas
    Schadendorf, Dirk
    Ribas, Antoni
    O'Day, Steven J.
    Sosman, Jeffrey A.
    Kirkwood, John M.
    Eggermont, Alexander M. M.
    Dreno, Brigitte
    Nolop, Keith
    Li, Jiang
    Nelson, Betty
    Hou, Jeannie
    Lee, Richard J.
    Flaherty, Keith T.
    McArthur, Grant A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26): : 2507 - 2516
  • [5] Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E-positive LCH
    Evseev, Dmitry
    Osipova, Daria
    Kalinina, Irina
    Raykina, Elena
    Ignatova, Anna
    Lyudovskikh, Evelina
    Baidildina, Dina
    Popov, Alexander
    Zhogov, Vladimir
    Semchenkova, Alexandra
    Litvin, Eugeny
    Kotskaya, Natalia
    Cherniak, Ekaterina
    Voronin, Kirill
    Burtsev, Eugeny
    Bronin, Gleb
    Vlasova, Irina
    Purbueva, Bazarma
    Fink, Olesya
    Pristanskova, Ekaterina
    Dzhukaeva, Irina
    Erega, Elena
    Novichkova, Galina
    Maschan, Alexey
    Maschan, Michael
    BLOOD ADVANCES, 2023, 7 (18) : 5246 - 5257
  • [6] Combination Atezolizumab, Cobimetinib, and Vemurafenib as a Treatment Option in BRAF V600 Mutation-Positive Melanoma: Patient Selection and Perspectives
    Dugan, Michelle M.
    Perez, Matthew C.
    Karapetyan, Lilit
    Zager, Jonathan S.
    CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 933 - 939
  • [7] Vemurafenib, Radiotherapy and Radiodermatitis in a Patient with malignant Melanoma and BRAF V600M Mutation
    Kigitsidou, E.
    Hein, R.
    Krackhardt, A.
    Specht, K.
    Ring, J.
    Belloni, B.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (09): : 947 - 948
  • [8] Cellular morphology of BRAF V600E-positive Langerhans cell histiocytosis
    Satpathy, Ansuman T.
    Tan, Brent T.
    BLOOD, 2015, 126 (15) : 1857 - 1857
  • [9] Successful Treatment With Vemurafenib in BRAF V600K-Positive Cerebral Melanoma Metastasis
    Forschner, Andrea
    Niessner, Heike
    Bauer, Juergen
    Bender, Benjamin
    Garbe, Claus
    Meier, Friedegund
    JAMA DERMATOLOGY, 2013, 149 (05) : 642 - 644
  • [10] BRAF V600E-Positive Congenital Multisite Langerhans Cell Histiocytosis
    Prada Avella, Maria Camila
    Suarez Sr, Amaranto
    Contreras, Sharon
    Calderon, Alejandra
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (09)
12345